Human medicines European public assessment report (EPAR): Pomalidomide Zentiva, pomalidomide, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 May 2026 - 15:55

Human medicines European public assessment report (EPAR): Pomalidomide Zentiva, pomalidomide, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/pomalidomide-zentiva

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters